Citation Impact
Citing Papers
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
1989
Crohn's disease in the elderly.
1985
Infective Endocarditis
2005 Standout
2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia
1990 StandoutScience
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Infliximab for acute, not steroid-refractory ulcerative colitis
2004
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Dynamics of fat cell turnover in humans
2008 StandoutNature
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus
2003
Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis
1996
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Cushing's syndrome
2015 Standout
Exploiting genomics, genetics and chemistry to combat antibiotic resistance
2003
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Oral Budesonide for Active Crohn's Disease
1994
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
1999 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Inflammatory Bowel Disease
1991 Standout
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Sepsis and septic shock
2018 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
Inflammatory Bowel Disease
1991
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
1987 Standout
Somatostatin Treatment and Risk Stratification by Continuous Portal Pressure Monitoring During Acute Variceal Bleeding
2001
Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation
2003
Population‐Based Study of the Epidemiology of and the Risk Factors for InvasiveStaphylococcus aureusInfections
2003
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
The Influence of Infection on Hospital Mortality for Patients Requiring > 48 h of Intensive Care
2003
High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections
2004
Acute Pancreatitis
1994 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
What We Talk About When We Talk About Fat
2014 Standout
Emerging drugs for the treatment of sepsis
2016
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Herpes Zoster
2013 Standout
Methotrexate for the Treatment of Crohn's Disease
1995
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Infective endocarditis
2004 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
2005
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
1993
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
The limitations of corticosteroid therapy in Crohn’s disease
2001
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
1993
Irritable Bowel Syndrome
2015 Standout
Ectopic ACTH Production in Carcinoma of the Lung
1974 StandoutNobel
Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis
1984 Standout
The clinical significance of inhibition of renal prostaglandin synthesis
1987
Maintenance Therapy in Crohn's Disease
2000
Clinical and Laboratory Studies of Ectopic Humoral Syndromes
1969
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
1994
LUNG TUMORS: HOW THEY PRODUCE THEIR SYNDROMES*
1974
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
1988 StandoutNobel
A Familial Visceral Myopathy
1978
Pharmacologic and Endocrine Aspects of Carcinoid Syndrome
1967
An epidemiological study of regional enteritis in the gloucester area
1973
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma
1975 StandoutNobel
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY
1982 StandoutNobel
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm
1983
Acute Drug and Toxin Induced Pancreatitis
1985
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins
1971
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease
1986
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus
2003
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.
1986 StandoutNobel
CROHN'S DISEASE IN SINGAPORE
1974
Ischemic Cell Death in Brain Neurons
1999 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Budesonide for induction of remission in Crohn's disease
2015
Traditional corticosteroids for induction of remission in Crohn's disease
2008
An Epidemiological Study of Ulcerative Colitis and Regional Enteritis Among Adults in Baltimore
1967
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Carcinoid-islet cell tumors of the duodenum
1971
Recent Developments in Nonspecific Inflammatory Bowel Disease
1982
National Cooperative Crohn's Disease Study: Results of drug treatment
1979
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
1996
Islet Cell Tumors: Current Concepts and Management
1973
The price of immunotherapy
1981
Body composition and adipose tissue cellularity before and after jejuno‐ileostomy in severely obese subjects
1977
Clinical Features and Epidemiological Data on Crohn's Disease in the Basle Area
1971
Crown Ethers: Sensors for Ions and Molecular Scaffolds for Materials and Biological Models
2004 Standout
Frequency of glucocorticoid resistance and dependency in Crohn's disease.
1994
Pancreatic Islet Cell Carcinoma
1973
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
1995 Standout
Sulfasalazine
1983
Works of David Law being referenced
Azathioprine-related pancreatitis in patients with Crohn's disease.
1979
Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
2002
Proton Pump Inhibitor Therapy Does Not Affect Hydrogen Production on Lactulose Breath Test in Subjects with IBS
2009
Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man
1983
Azathioprine-related pancreatitis in patients with Crohn's disease
1979
Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis
1984
Changes in body composition after jejunoileal bypass in morbidly obese patients
1972
Regional Enteritis
1969
Brain Amino Acids Measured by Intracerebral Dialysis in Portacaval Shunted Rats
1983
Ectopic Production of Multiple Hormones (ACTH, MSH and Gastrin) by a Single Malignant Tumor
1965
Crohn's disease, 1961–1971
1972
Ulcerative Colitis with Onset after the Age of Fifty
1961
Malabsorption syndrome associated with metastatic carcinoid tumor
1959
National Cooperative Crohn's Disease Study: Adverse reactions to study drugs
1979
Urinary Excretion of 5-Hydroxyindolacetic Acid in Diarrheal States, with Special Reference to Nontropical Sprue
1958
Familial megaduodenum and megacystis
1962